Search Results - Madhusudan, Srinivasan

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    DNA repair in cancer: emerging targets for personalized therapy

    DNA repair in cancer: emerging targets for personalized therapy by Abbotts, Rachel, Thompson, Nicola, Madhusudan, Srinivasan

    Published 2014
    Get full text
  2. 2
    Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer

    Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer by Abbotts, Rachel, Perry, Christina, Madhusudan, Srinivasan

    Published 2011
    Get full text
  3. 3
    RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner

    RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner by Parvathaneni, Swetha, Lu, Xing, Choudhary, Ritu, Lal, Ashish, Madhusudan, Srinivasan, Sharma, Sudha

    Published 2017
    Get full text
  4. 4
    The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays

    The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays by Tewari, Nilanjana, Zaitoun, Abed M., Arora, Arvind, Madhusudan, Srinivasan, Ilyas, Mohammad, Lobo, Dileep N.

    Published 2013
    Get full text
  5. 5
    Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy

    Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy by Fareed, Khaleel R., Soomro, Irshad N., Hameed, Khalid, Arora, Arvind, Lobo, Dileep N., Parsons, Simon L., Madhusudan, Srinivasan

    Published 2012
    Get full text
  6. 6
    Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla

    Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla by Storr, Sarah J., Zaitoun, Abed M., Arora, Arvind, Durrant, Lindy G., Lobo, Dileep N., Madhusudan, Srinivasan, Martin, Stewart G.

    Published 2012
    Get full text
  7. 7
    Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells

    Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells by Sultana, Rebeka, Abdel-Fatah, Tarek, Perry, Christina, Moseley, Paul, Albarakti, Nada, Mohan, Vivek, Seedhouse, Claire, Chan, Stephan, Madhusudan, Srinivasan

    Published 2013
    Get full text
  8. 8
    LY2495655, an antimyostatin antibody in pancreatic cancer: a randomized phase 2 trial

    LY2495655, an antimyostatin antibody in pancreatic cancer: a randomized phase 2 trial by Golan, Talia, Geva, Ravit, Richards, Donald, Madhusudan, Srinivasan, Lin, Boris Kin, Wang, Haofei Tiffany, Walgren, Richard A., Stemmer, Salomon M.

    Published 2018
    Get full text
  9. 9
    Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers

    Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers by Green, Andrew R., Aleskandarany, Mohammed A., Ali, Reem, Hodgson, Eleanor Grace, Atabani, Suha, De Souza, Karen, Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan

    Published 2017
    Get full text
  10. 10
    Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

    Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein by Alshareeda, Alaa, Negm, Ola H., Aleskandarany, Mohammed A., Green, Andrew R., Nolan, Christopher, Tighe, Patrick J., Madhusudan, Srinivasan, Ellis, Ian O., Rakha, Emad

    Published 2016
    Get full text
  11. 11
    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy

    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy by Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y.T., Green, Andrew R., Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan

    Published 2018
    Get full text
  12. 12
    Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?

    Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer? by Abdel-Fatah, Tarek, Arora, Arvind, Gorguc, Ipek, Abbotts, Rachel, Beebeejaun, Sarah, Storr, Sarah J., Mohan, Vivek, Hawkes, Claire, Soomro, Irshad N., Lobo, Dileep N., Parsons, Simon L., Madhusudan, Srinivasan

    Published 2013
    Get full text
  13. 13
    Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway

    Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway by Mo, Dongliang, Fang, Hongbo, Niu, Kaifeng, Liu, Jing, Wu, Meng, Li, Shiyou, Zhu, Tienian, Aleskandarany, Mohammed A., Arora, Arvind, Lobo, Dileep N., Madhusudan, Srinivasan, Balajee, Adayabalam S., Chi, Zhenfen, Zhao, Yongliang

    Published 2016
    Get full text
  14. 14
    Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers

    Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers by Arora, Arvind, Parvathaneni, Swetha, Aleskandarany, Mohammed A., Agarwal, Devika, Ali, Reem, Abdel-Fatah, Tarek, Green, Andrew R., Ball, Graham R., Rakha, Emad A., Ellis, Ian O., Sharma, Sudha, Madhusudan, Srinivasan

    Published 2017
    Get full text
  15. 15
    Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer

    Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer by Arora, Arvind, Abdel-Fatah, Tarek, Agarwal, Devika, Doherty, Rachel, Moseley, Paul M., Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Alshareeda, Alaa, Rakha, Emad, Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan

    Published 2015
    Get full text
  16. 16
    The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

    The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response by Barone, Giancarlo, Arora, Arvind, Ganesh, Anil, Abdel-Fatah, Tarek, Moseley, Paul, Ali, Reem, Chan, Stephen Y.T., Savva, Constantinos, Schiavone, Kristina, Carmell, Natasha, Myers, Katie N., Rakha, Emad A., Madhusudan, Srinivasan, Collis, Spencer J.

    Published 2018
    Get full text
  17. 17
    Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

    Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial by Ford, Hugo, Marshall, Andrea, Bridgewater, John A., Janowitz, Tobias, Coxon, Fareeda, Wadsley, Jonathan, Mansoor, Wasat, Fyfe, David, Madhusudan, Srinivasan, Middleton, Gary, Swinson, Daniel, Falk, Stephen, Chau, Ian, Cunningham, David, Kareclas, Paula, Cook, Natalie, Blazeby, Jane M., Dunn, Janet A.

    Published 2014
    Get full text
  18. 18
    RECQL4 helicase has oncogenic potential in sporadic breast cancers

    RECQL4 helicase has oncogenic potential in sporadic breast cancers by Arora, Arvind, Agarwal, Devika, Abdel-Fatah, Tarek M.A., Lu, Huiming, Croteau, Deborah L., Moseley, Paul, Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Rakha, Emad A., Chan, Stephen Y.T., Ellis, Ian O., Wang, Lisa L., Zhao, Yongliang, Balajee, Adayabalam S., Bohr, Vilhelm A., Madhusudan, Srinivasan

    Published 2016
    Get full text
  19. 19
    Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial

    Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial by Backen, Alison C., Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H., Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G., Madhusudan, Srinivasan, Maraveyas, Anthony, Ross, Paul J., Waters, Justin S., Steward, William P., Rees, Charlotte, McNamara, Mairéad G., Beare, Sandy, Bridgewater, John A., Dive, Caroline, Valle, Juan W.

    Published 2018
    Get full text
  20. 20
    Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial

    Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre ph... by Middleton, Gary, Palmer, Daniel H., Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony, Shaw, Victoria E., Wadsley, Jonathan, Valle, Juan W., Propper, David, Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda, Ross, Paul, Madhusudan, Srinivasan, Wadd, Nick, Corrie, Pippa, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte, Neoptolemos, John P.

    Published 2017
    Get full text

Search Tools: